Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Ayesha Fawad, Sophie M. van der Landen, Pontus Tideman, Angela van der Putten‐Toorenburg, Elke Butterbrod, Ruben Smith, Danielle van Westen, Susanna Calling, Patrik Midlöv, Niklas Mattsson‐Carlgren, Beata Borgström Bolmsjö, Erik Stomrud, Maria H. Nilsson, Oskar Hansson, Sietske A. M. Sikkes, Sebastian Palmqvist |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2026
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Performance of the Amsterdam IADL scale in Assessing Functional Decline among Older People in Primary Health Care
por: Ayesha Fawad, et al.
Publicado: (2024)
por: Ayesha Fawad, et al.
Publicado: (2024)
Performance of the Amsterdam IADL scale in Assessing Functional Decline among Older People in Primary Health Care
por: Ayesha Fawad, et al.
Publicado: (2024)
por: Ayesha Fawad, et al.
Publicado: (2024)
A self‐administered digital cognitive test together with a blood test accurately detect clinical Alzheimer's disease in primary care
por: Pontus Tideman, et al.
Publicado: (2025)
por: Pontus Tideman, et al.
Publicado: (2025)
The relationship between cognitive screeners and everyday functioning in amyloid‐positive participants from the Amsterdam Dementia Cohort
por: Angela van der Putten‐Toorenburg, et al.
Publicado: (2026)
por: Angela van der Putten‐Toorenburg, et al.
Publicado: (2026)
The MRI signature of alpha‐synuclein pathology in preclinical stages and in a memory clinic population
por: Laura E.M. Wisse, et al.
Publicado: (2024)
por: Laura E.M. Wisse, et al.
Publicado: (2024)
Bridging the Gap between Cognition and Everyday Functioning: A linking Study in Amyloid Positive Participants
por: Angela van der Putten‐Toorenburg, et al.
Publicado: (2024)
por: Angela van der Putten‐Toorenburg, et al.
Publicado: (2024)
Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer’s disease
por: David Berron, et al.
Publicado: (2024)
por: David Berron, et al.
Publicado: (2024)
Discriminating AD Biomarker Groups Based on a Digital Speech Biomarker for Cognition (SB‐C)
por: Alexandra König, et al.
Publicado: (2025)
por: Alexandra König, et al.
Publicado: (2025)
Longitudinal tau‐PET accumulation and downstream effects in amyloid‐beta negative cognitively unimpaired individuals
por: Anika Wuestefeld, et al.
Publicado: (2025)
por: Anika Wuestefeld, et al.
Publicado: (2025)
Comparison of plasma biomarkers measured on a fully automated instrument versus CSF biomarkers for detecting Alzheimer’s disease pathology
por: Noëlle Warmenhoven, et al.
Publicado: (2025)
por: Noëlle Warmenhoven, et al.
Publicado: (2025)
Test‐retest reliability and feasibility of web‐based cognitive assessment cCOG
por: Sophie M. van der Landen, et al.
Publicado: (2025)
por: Sophie M. van der Landen, et al.
Publicado: (2025)
A proposed medical system change in Japan inspired by Swedish primary health care: Important role of general practitioners and specialist nurses at primary health care centers
por: Rie Sato, et al.
Publicado: (2024)
por: Rie Sato, et al.
Publicado: (2024)
Evaluation of the prospective use of blood biomarkers for Alzheimer’s disease in primary and secondary care
por: Sebastian Palmqvist, et al.
Publicado: (2024)
por: Sebastian Palmqvist, et al.
Publicado: (2024)
Self‐Efficacy in Hypertension Management Using e‐Health Technology: A Randomized Controlled Trial in Primary Care
por: Rasmus Hermansson‐Borrebaeck, et al.
Publicado: (2025)
por: Rasmus Hermansson‐Borrebaeck, et al.
Publicado: (2025)
Impact of regional MAPT, APOE, and Aβ on tau propagation in Alzheimer’s disease: Insights from a connectome‐based simulation model
por: Yu Xiao, et al.
Publicado: (2024)
por: Yu Xiao, et al.
Publicado: (2024)
Can longitudinal measures of plasma biomarkers track disease progression in early Alzheimer´s Disease?
por: Divya Bali, et al.
Publicado: (2025)
por: Divya Bali, et al.
Publicado: (2025)
APOE ε4 ‐related proteomic profiles in plasma and CSF
por: Lina Lu, et al.
Publicado: (2025)
por: Lina Lu, et al.
Publicado: (2025)
CSF and plasma proteomic insights into the pathophysiology of cerebral small vessel disease and cerebrovascular event risk prediction
por: Ines Hristovska, et al.
Publicado: (2025)
por: Ines Hristovska, et al.
Publicado: (2025)
Can we Evaluate RAGs with Synthetic Data?
por: van Elburg, Jonas, et al.
Publicado: (2025)
por: van Elburg, Jonas, et al.
Publicado: (2025)
Amyloid‐related changes in fluency in patients with subjective cognitive decline
por: Rosanne L. van den Berg, et al.
Publicado: (2025)
por: Rosanne L. van den Berg, et al.
Publicado: (2025)
Clinical performance of blood biomarkers across settings and countries
por: Sebastian Palmqvist, et al.
Publicado: (2025)
por: Sebastian Palmqvist, et al.
Publicado: (2025)
Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [ 18 F]flortaucipir imaging
por: Emma M. Coomans, et al.
Publicado: (2025)
por: Emma M. Coomans, et al.
Publicado: (2025)
Associations between tau accumulation and cognitive decline across the AD continuum differ by sex
por: Ellen Hanna Singleton, et al.
Publicado: (2024)
por: Ellen Hanna Singleton, et al.
Publicado: (2024)
Associations between tau accumulation and cognitive decline across the AD continuum differ by sex
por: Ellen Hanna Singleton, et al.
Publicado: (2024)
por: Ellen Hanna Singleton, et al.
Publicado: (2024)
Amyloid‐positivity is characterized by decline in semantic fluency: An in‐depth investigation of verbal fluency trajectories, item‐level characteristics and its prognostic value in patients with subjective cognitive decline
por: Rosanne L. van den Berg, et al.
Publicado: (2024)
por: Rosanne L. van den Berg, et al.
Publicado: (2024)
Hemispheric Asymmetry of Amyloid Deposition Influences Asymmetric Tau Pathology in Alzheimer's Disease
por: Toomas Erik Anijärv, et al.
Publicado: (2025)
por: Toomas Erik Anijärv, et al.
Publicado: (2025)
The Impacts of AI Avatar Appearance and Disclosure on User Motivation
por: Visser, Boele, et al.
Publicado: (2024)
por: Visser, Boele, et al.
Publicado: (2024)
Limit of nonlinear Signorini problems for incompressible materials
por: Mainini, Edoardo, et al.
Publicado: (2024)
por: Mainini, Edoardo, et al.
Publicado: (2024)
Predicting cognitive decline in amyloid‐negative individuals with amnestic mild cognitive impairment
por: Amanda Annettesdotter, et al.
Publicado: (2025)
por: Amanda Annettesdotter, et al.
Publicado: (2025)
Predicting cognitive decline in amyloid‐negative individuals with amnestic mild cognitive impairment
por: Amanda Annettesdotter, et al.
Publicado: (2025)
por: Amanda Annettesdotter, et al.
Publicado: (2025)
Reasoning Promotes Robustness in Theory of Mind Tasks
por: de Haan, Ian B., et al.
Publicado: (2026)
por: de Haan, Ian B., et al.
Publicado: (2026)
Everyday functioning beyond cognition: Using Structural Equation Modelling to explore relationships between cognitive domains and everyday functioning in Alzheimer’s disease
por: Sophie M. van der Landen, et al.
Publicado: (2024)
por: Sophie M. van der Landen, et al.
Publicado: (2024)
Quranic Arabic
por: van Putten, Marijn
Publicado: (2022)
por: van Putten, Marijn
Publicado: (2022)
al-Dānī's al-Taysīr fī al-qirāʾāt al-sabʿ
por: van Putten, Marijn
Publicado: (2026)
por: van Putten, Marijn
Publicado: (2026)
Clinical usefulness of plasma p ‐tau217 and eMTBR‐tau243 combination for diagnosis and patient stratification
por: Niklas Mattsson‐Carlgren, et al.
Publicado: (2025)
por: Niklas Mattsson‐Carlgren, et al.
Publicado: (2025)
Mirror Mode in Fire Emblem: Beating Players at their own Game with Imitation and Reinforcement Learning
por: Smid, Yanna Elizabeth, et al.
Publicado: (2025)
por: Smid, Yanna Elizabeth, et al.
Publicado: (2025)
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
por: Lyduine E. Collij, et al.
Publicado: (2024)
por: Lyduine E. Collij, et al.
Publicado: (2024)
Proteomic profiles in Lewy body pathology and the presence of AD co‐pathology
por: Irene Cumplido‐Mayoral, et al.
Publicado: (2025)
por: Irene Cumplido‐Mayoral, et al.
Publicado: (2025)
Complementary utility of plasma biomarkers and Aβ‐PET for diagnosis, risk‐stratification, and treatment monitoring in Alzheimer's disease
por: Lyduine E. Collij, et al.
Publicado: (2025)
por: Lyduine E. Collij, et al.
Publicado: (2025)
De regio als bestuurlijk schaalniveau
por: Hooge, Edith, et al.
Publicado: (2022)
por: Hooge, Edith, et al.
Publicado: (2022)
Ejemplares similares
-
Performance of the Amsterdam IADL scale in Assessing Functional Decline among Older People in Primary Health Care
por: Ayesha Fawad, et al.
Publicado: (2024) -
Performance of the Amsterdam IADL scale in Assessing Functional Decline among Older People in Primary Health Care
por: Ayesha Fawad, et al.
Publicado: (2024) -
A self‐administered digital cognitive test together with a blood test accurately detect clinical Alzheimer's disease in primary care
por: Pontus Tideman, et al.
Publicado: (2025) -
The relationship between cognitive screeners and everyday functioning in amyloid‐positive participants from the Amsterdam Dementia Cohort
por: Angela van der Putten‐Toorenburg, et al.
Publicado: (2026) -
The MRI signature of alpha‐synuclein pathology in preclinical stages and in a memory clinic population
por: Laura E.M. Wisse, et al.
Publicado: (2024)